Washington, D.C. – Arcellx’s iMMagine-1 Phase II clinical program has received approval from the FDA to resume testing its CART-ddBCMA treatment for patients with relapsed or refractory multiple myeloma, following a temporary hold on the trial earlier this year. The company announced this development on Monday, signaling a positive step forward for the innovative cell … Read more
After multiple myeloma was diagnosed in Judith Harding in 2009, she made drastic life changes, expecting the worst. Meanwhile, Bill McHugh underwent a stem cell transplant for the same type of blood cancer in 2013. Their survival was once considered exceptional, but thanks to recent advancements in treatment, they are now considered typical multiple myeloma … Read more
Maine, the state that was shattered three months ago by a mass shooting at a bar and a bowling alley, is now reeling from new revelations about the alleged shooter’s troubling behavior leading up to the tragic event. Recent body camera footage from July shows that the accused shooter, Robert Card, was involved in an … Read more
GENEVA, Switzerland – Sepsis, a life-threatening condition triggered by the body’s extreme response to infection, poses a serious global health threat. It can lead to organ failure and death, affecting hundreds of millions of patients worldwide each year. Sepsis is usually caused by bacterial infections but may also result from viruses, parasites, or fungi. People … Read more